Equity Overview
Price & Market Data
Price: $0.408
Daily Change: -$0.0189 / 4.63%
Daily Range: $0.40 - $0.428
Market Cap: $32,039,212
Daily Volume: 286,508
Performance Metrics
1 Week: -8.38%
1 Month: -50.49%
3 Months: -52.06%
6 Months: -57.86%
1 Year: -62.86%
YTD: -56.60%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.